Related Experiment Video
Updated: May 14, 2026

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)
Published on: February 9, 2011
Community-acquired methicillin-resistant Staphylococcus aureus nasal abscesses in a lower socioeconomic urban
Andrea S Wang1, Rita M Roure, Aaron N Pearlman
1Department of Otolaryngology-Head and Neck Surgery, Weill Cornell Medical College, New York, NY, USA.
Background:
To determine the prevalence of community-acquired methicillin-resistant S. aureus (CA-MRSA) and methicillin-sensitive S. aureus (MSSA) nasal abscesses in a lower socioeconomic status urban population over a 5-year period.
Methods:
A retrospective chart review of 29 consecutive patients with nasal abscess cultures performed in the otolaryngology clinic from 2007 to 2012.
Results:
Twenty-nine cases of nasal abscesses were identified. All cultures grew S. aureus; 34.5% were MSSA and 65.5% were CA-MRSA. Comparing CA-MRSA and MSSA, there was no statistically significant increase in prevalence of CA-MRSA over 5 years; and there was no statistical difference comparing gender, year, or age. There was a high rate of erythromycin resistance (15/19) and a low rate of sulfamethoxazole/trimethoprim (2/19) and clindamycin (1/19) resistance in the CA-MRSA cases.
Conclusion:
In this population, the proportion of CA-MRSA nasal abscesses is nearly twice that of MSSA nasal abscesses. The overall prevalence of CA-MRSA appears to be stable over the past 5 years. This may represent a stabilization of CA-MRSA colonization in this community. An awareness of the high proportion of CA-MRSA will allow for the appropriate selection of antibiotic therapy.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Staphylococcal Skin Infections
Mechanism of Antibiotic Resistance in MRSA
Microbiota of the Respiratory Tract
Brain Abscess l: Introduction
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies. Common...